|
PALB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.10069999998053E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.755500E-03 |
| Normal-vs-Stage2 |
2.223700E-02 |
| Normal-vs-Stage3 |
3.479100E-03 |
| Normal-vs-Stage4 |
7.512400E-02 |
| Stage1-vs-Stage2 |
2.942000E-01 |
| Stage1-vs-Stage3 |
8.730400E-02 |
| Stage1-vs-Stage4 |
7.624400E-01 |
| Stage2-vs-Stage3 |
7.289600E-01 |
| Stage2-vs-Stage4 |
6.695800E-01 |
| Stage3-vs-Stage4 |
4.792600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68550000001488E-06 |
| Normal-vs-AfricanAmerican |
5.250400E-02 |
| Normal-vs-Asian |
3.426800E-01 |
| Caucasian-vs-AfricanAmerican |
3.594100E-02 |
| Caucasian-vs-Asian |
4.504400E-01 |
| AfricanAmerican-vs-Asian |
8.494200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.23079999999554E-05 |
| Normal-vs-Female |
1.163460E-04 |
| Male-vs-Female |
2.264000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.744400E-02 |
| Normal-vs-Extreme_Weight |
3.956300E-02 |
| Normal-vs-Obese |
2.633300E-04 |
| Normal-vs-Extreme_Obese |
3.974200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.279600E-01 |
| Normal_Weight-vs-Obese |
1.498210E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.165600E-01 |
| Extreme_Weight-vs-Obese |
2.465600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.971200E-01 |
| Obese-vs-Extreme_Obese |
3.040600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.699900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.92009999997212E-06 |
| Normal-vs-Age(61-80Yrs) |
1.715310E-03 |
| Normal-vs-Age(81-100Yrs) |
5.689400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.421800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.520200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.920000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.557840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.138810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.444000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.800200E-04 |
| Normal-VS-Type2 PRCC |
1.842990E-03 |
| Normal-VS-KIRP CIMP |
1.216800E-01 |
| Normal-VS-Unclassified PRCC |
1.524640E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.236400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.863800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.697900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.360800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.314370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.677400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.906400E-02 |
| Normal-vs-N1 |
2.462700E-03 |
| Normal-vs-N2 |
7.724400E-01 |
| N0-vs-N1 |
4.392000E-02 |
| N0-vs-N2 |
7.453800E-01 |
| N1-vs-N2 |
2.662800E-01 |
|
|
